Yale researchers have developed a new vaccine that does double duty against a rare and aggressive skin cancer by targeting ...
Messenger RNA, or mRNA, vaccines entered the public consciousness when they were introduced during the COVID-19 pandemic, and both Pfizer-BioNTech and Moderna used the technology in developing their ...
Live Science on MSNOpinion
One molecule could usher revolutionary medicines for cancer, diabetes and genetic disease — but the US is turning its back on it
The U.S. government is divesting from mRNA vaccines, but will other uses of the technology be spared? In a time of ...
Artificial intelligence is getting really good at helping doctors diagnose problems and even discover new drugs faster. It ...
However, the research team head cautioned that it is still too early to recommend the mRNA COVID-19 vaccine as a standard part of cancer therapy.
Messenger RNA, or mRNA, vaccines entered the public consciousness when they were introduced during the COVID-19 pandemic, and both Pfizer-BioNTech and Moderna used the technology in developing their ...
As BioNTech works to establish a production footprint for mRNA vaccines in Africa, two EU groups have offered financial backing to the company's efforts. The European Commission pledged a 35 million ...
Shares of biotechnology company Moderna (NASDAQ:MRNA) fell 6.9% in the afternoon session after ongoing concerns about its ...
In the latest trading session, Moderna (MRNA) closed at $26.85, marking a -2.33% move from the previous day. The stock's performance was behind the S&P 500's daily loss of 0.53%. Elsewhere, the Dow ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback